FDA
-
-
-
-
-
-
-
Biophytis Gives Operational Perspectives on its Sarconeos (BIO101) Ahead of its Upcoming AGM on April 26, 2021
-
-
-
-
-
-
-
Biophytis Announces a € 6.1 Million Capital Increase Through Private Placement
-
-
-
-
-
-
-
BIOPHYTIS: Inclusion of the First Patient in Phase 2b Study in Sarcopenia
-
-
-
-
-
-
-
BIOPHYTIS completes a €10.4 M capital increase to finance mid-stage clinical trials for two novel anti-aging drug-candidates
-
-
251,402 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All